SFI — Sopharma Properties ADSITS Income Statement
0.000.00%
Last trade - 00:00- €108.88m
- €108.46m
- BGN18.70m
- 59
- 34
- 47
- 40
Annual income statement for Sopharma Properties ADSITS, fiscal year end - December 31st, BGN millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 12.7 | 14.6 | 16.3 | 19.6 | 18.7 |
| Cost of Revenue | |||||
| Gross Profit | 9.45 | 10.8 | 12.2 | 15.4 | 14.2 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 3.43 | 4.17 | 4.28 | 4.51 | 4.78 |
| Operating Profit | 9.26 | 10.4 | 12 | 15 | 13.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 9.07 | 10.3 | 11.8 | 15.1 | 14 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 9.07 | 10.3 | 11.8 | 15.1 | 14 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 9.07 | 10.3 | 11.8 | 15.1 | 14 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 9.07 | 10.3 | 11.8 | 15.1 | 14 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.415 | 0.479 | 0.539 | 0.694 | 0.639 |
| Dividends per Share |